EUCCK urges Korean government to create A7 pricing for innovative new products

Published: 2003-04-07 07:00:00

Updated: 2003-04-07 07:00:00

The European Union Chamber of Commerce in Korea (EUCCK) called on the Korean government to revamp its pharmaceutical reimbursement system including drug-related policies, according to a report.

During the EUCCK-organized press reference with the local media to present the organization's list o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK